Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi launches French eHealth laboratory 39BIS

The digital lab will focus on its home market and is based near Paris

Sanofi 39BIS digital laboratory France

Sanofi has launched a ‘digital laboratory’ just outside Paris that will be dedicated to advancing its eHealth work in France.

Known as 39BIS, the lab is a first for both the French pharma company and its home country. It aims to connect Sanofi employees with representatives from a wide variety of other companies and stakeholders within the eHealth environment.

Sanofi’s country chair for France Guillaume Leroy said: “"We are convinced that e-health will make a significant contribution to changing our healthcare system and improving patient care.

“We are proud to make available to everyone 39BIS, a unique place to accelerate the development of e-solutions for healthcare professionals and patients in their life course.”

Sanofi’s eHealth strategy in France is focused on healthcare professionals - including dispensing pharmacists - and medicines, pharmacovigilance, skin disorder diagnosis and exploring diagnostics in rare diseases and vaccines.

As part of its efforts to develop eHealth solutions the firm aims to harness areas such as connected objects, big data, block chain, serious games and artificial intelligence.

Dmd Santé, France eHealth Tech and Umanlife are among the laboratory’s initial external partners and its offering will include a six-month project process.

Isabelle Vitali, director innovation and business excellence at Sanofi France, characterised the space as “a place of daring where one has the right to explore, to experiment or even to err in order to advance”.

Leroy said earlier this year: “In e-health, we are only at the beginning, but the potential is enormous. In France, we already offer e-solutions in our areas of expertise, such as cardiovascular diseases, rare diseases and pain management.

“In diabetes, Sanofi has developed several mobile applications as well as a telemedicine solution that has received a positive opinion for reimbursement in France.”

39BIS is located at the Sanofi’s Val de Bièvre campus just south of Paris in Gentilly, where it offers a showroom, a co-creation ideation space and a prototyping area.

“With this location, we will be able to anchor Sanofi’s digital strategy and interact increasingly with the ecosystem, including startups, schools, incubators and large companies,” Leroy said.

“The 39BIS will offer a scalable offer of services and training to accelerate our ambitions in e-health. It is an important new step in our strong commitment to digital health.”

12th December 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics